Globus Medical Inc
- Stock
- Ticker GMED
- ISIN US3795772082
- NYSE
Performance, volatility and drawdowns of Globus Medical Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $31,199. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −47.9% in 11/2023, measured from the peak in 09/2021. It took 38 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 657 | 598 | 745 | 769 | 826 | 760 | 790 | 764 |
| Gross profit | 394 | 403 | 497 | 517 | 565 | 526 | 548 | 531 |
| Operating income | 60 | 97 | 76 | 137 | 169 | 150 | 182 | 178 |
| EBITDA | 128 | 163 | 117 | 179 | 239 | 220 | 223 | 219 |
| Net income | 27 | 75 | 203 | 119 | 141 | 124 | 152 | 141 |
| Earnings per share | 0.19 | 0.54 | 1.49 | 0.88 | 1.02 | 0.90 | 1.10 | 1.04 |
| Balance sheet | ||||||||
| Total assets | 5,252 | 4,711 | 4,961 | 5,096 | 5,303 | 5,440 | 5,488 | 5,528 |
| Liabilities | 1,074 | 623 | 665 | 697 | 730 | 707 | 720 | 732 |
| Equity | 4,177 | 4,088 | 4,296 | 4,399 | 4,573 | 4,732 | 4,769 | 4,796 |
| Cash | 784 | 461 | 229 | 372 | 526 | 561 | 508 | 441 |
| Cash flow | ||||||||
| Operating cash flow | 210 | 177 | 78 | 250 | 249 | 202 | 210 | 265 |
| Capital expenditure | -17 | -36 | -47 | -36 | -46 | -40 | -33 | -40 |
| Free cash flow | 193 | 141 | 31 | 214 | 202 | 163 | 177 | 225 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +65.7%, weakest 2023 at −28.2%. 8 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $1.04 |
| 6 Aug 2026 | $1.10 |
| 7 May 2026 | $0.90 |
| 24 Feb 2026 | $1.02 |
| 6 Nov 2025 | $0.88 |
| 7 Aug 2025 | $1.49 |
| 8 May 2025 | $0.54 |
| 20 Feb 2025 | $0.19 |
| 5 Nov 2024 | $0.38 |
| 6 Aug 2024 | $0.23 |
| 7 May 2024 | −$0.05 |
| 21 Feb 2024 | $0.09 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €8.2bn
- Market cap in trading currency
- $9.10bn
- Enterprise value
- $8.58bn
- P/E
- 16.5
- P/S
- 2.90
- P/B
- 1.90
- EV/Sales
- 2.73
- EV/EBITDA
- 9.5
- Earnings yield
- 6.1%
- FCF yield
- 8.4%
Results (last four quarters)
- Revenue
- $3.14bn
- Gross profit
- $2.17bn
- EBITDA
- $901m
- Net income
- $558m
- Earnings per share
- $4.06
- Revenue per share
- $23.08
- Revenue growth
- −0.7%
- Earnings growth
- +18.7%
Profitability
- Gross margin
- 69.1%
- Operating margin
- 21.6%
- Net margin
- 17.8%
- Return on equity
- 12.1%
- Return on assets
- 10.1%
Balance sheet and cash flow
- Cash
- $517m
- Cash per share
- $3.80
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 4.30
- Book value per share
- $35.26
- Operating cash flow
- $926m
- Free cash flow
- $767m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 136m
- Volume
- 1.51m
- Avg. volume 3 months
- 1.61m
- Relative volume
- 0.9
Price and technicals
- Price
- $66.89
- 1 day
- −2.5%
- 52-week high
- $96.82
- 52-week low
- $66.89
- Distance to 52-week high
- −30.9%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −12.0%
- Distance to 200-day line
- −18.6%
- RSI (14)
- 35
- Volatility 1M
- 73.8%
Performance
- 1 week
- −7.3%
- 1 month
- −18.1%
- 3 months
- −20.4%
- 6 months
- −21.1%
- YTD
- −23.4%
- 1 year
- −20.2%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has GMED performed since 11/2016?
$10,000 grew to $31,199 by 20 Nov 2026, which is +12.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is GMED?
Volatility was 35.7% per year, measured on monthly returns. The largest decline from a peak was −47.9%, with the low in 11/2023.
How does GMED compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, GMED returned +12.1% at 35.7%. The correlation of monthly returns was 0.47; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.